We examined whether prolactin concentrations correlate with disease severity or worse outcomes and evaluated correlations with key interleukins involved in COVID-19 inflammatory mechanisms to support its role in immunological pathways, and our findings provide valuable insights into the role of PRL in COVID-19 patients with moderate to severe disease. This evidence concerns the gene PRL and COVID-19.